Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.
Saved in:
| Title: | Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium. |
|---|---|
| Authors: | Bettegowda C; Department of Neurosurgery, Johns Hopkins Khatib Brain Tumor Center, Johns Hopkins University, Baltimore, USA., Noushmehr H; Department of Neurosurgery, Henry Ford Health System, Detroit, Michigan, USA., Affinito A; Department of Molecular Medicine and Medical Biotechnology, Federico II University, Napoli, Italy., Ahluwalia MS; Miami Cancer Institute, and Florida International University, Miami, Florida, USA., Ansorge O; Neuropathology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Ayasoufi K; Department of Neurosurgery, Duke University, Durham, North Carolina, USA., Bagley S; University of Pennsylvania, Philadelphia, Pennsylvania, USA., Barnholtz-Sloan J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Best M; Department of Neurosurgery, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Brandsma D; Department of Neuro-Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Brodie C; Faculty of Life Sciences and the Institute of Nanotechnology and Advanced Materials (BINA), Bar-Ilan University, Ramat-Gan, Israel., Brüning-Richardson A; School of Applied Sciences, University of Huddersfield, Huddersfield, UK., Castro AV; Department of Neurosurgery, Henry Ford Health System, Detroit, Michigan, USA.; Department of Physiology, Michigan State University, East Lansing, MI, USA., Chang SM; Division of Neuro-Oncology, Department of Neurosurgery, University of California, San Francisco, California, USA., Condorelli G; Department of Molecular Medicine and Medical Biotechnology, Federico II University, Napoli, Italy., Daher A; Department of Neurology& Rehabilitation, University of Illinois at Chicago, Chicago, Illinois, USA., Datta V; Department of Research and Innovations, Datar Cancer Genetics, Nasik, India., de Groot J; Division of Neuro-Oncology, Department of Neurosurgery, University of California, San Francisco, California, USA., French P; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Galanis E; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Golebiewska A; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg., Hamerlik P; Division of Cancer Sciences, University of Manchester, Manchester, UK., Hanemann CO; Peninsula Medical School, University of Plymouth, Plymouth, UK., Holdhoff M; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Huse J; Departments of Pathology and Translational Molecular Pathology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA., Khasraw M; Department of Neurosurgery, Duke University, Durham, North Carolina, USA., LeBlang S; Clinical Relationships, Focused Ultrasound Foundation, Charlottesville, Virginia, USA., Melin B; Department of Diagnostics and Intervention Oncology, Umeå University, Umeå Sweden., Mouliere F; Cancer Research UK National Biomarker Centre, University of Manchester, UK., O'Leary C; Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Rak J; Department of Pediatrics, McGill University, Montreal, Quebec, Canada., Ray A; Apollo Hospitals and Exsegen Genomics Research, Hyderabad, India., Robinson S; Department of Biochemistry and Biomedicine, University of Sussex, Brighton, UK., Rominiyi O; Division of Neuroscience, University of Sheffield and Department of Neurosurgery, Sheffield Teaching Hospitals, Sheffield, UK., Roncaroli F; Division of Neuroscience, University of Manchester, Manchester, UK., Rudà R; Division of Neuro-Oncology, Department Neuroscience 'Rita Levi Montalcini', University of Turin, Turin, Italy., Seoane J; Vall d'Hebron Institute of Oncology (VHIO) and University, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Sol N; Department of Neuro-Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Bent MJ; Department Neuro-Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Vogelbaum MA; Department of Neuro-Oncology, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Walbert T; Department of Neurology, University of Zurich, Zurich, Switzerland.; Departments of Neurosurgery and Neurology, Wayne State University, Detroit, Michigan, USA., Watts C; Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Weiss T; Department of Neurology, University of Zurich, Zurich, Switzerland., Weller M; Department of Neurology, University of Zurich, Zurich, Switzerland., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Wykes V; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Yip S; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Short SC; Leeds Institute of Medical Research, The University of Leeds, Leeds, UK., Soffietti R; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy. |
| Source: | Neuro-oncology [Neuro Oncol] 2025 Oct 01; Vol. 27 (10), pp. 2496-2513. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
